InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

- Current share price for 4DX : $3.640

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,184 Cleansing Notice 19 Dec 2025 3:41PM $3.510 $3.640 risen by 3.70%
$2,184 Application for quotation of securities - 4DX 19 Dec 2025 3:40PM $3.510 $3.640 risen by 3.70%
$2,184 Application for quotation of securities - 4DX 19 Dec 2025 3:39PM $3.545 $3.640 risen by 2.68%
$2,184 Cleveland Clinic adopts CTVQ 19 Dec 2025 9:06AM $2.890 $3.640 risen by 25.95%
$2,184 Change of Director's Interest Notice AF, GM, JL, JS, LB & RF 18 Dec 2025 3:45PM $2.940 $3.640 risen by 23.81%
$2,184 Notification regarding unquoted securities - 4DX 18 Dec 2025 3:30PM $2.935 $3.640 risen by 24.02%
$2,184 Application for quotation of securities - 4DX 18 Dec 2025 3:20PM $2.945 $3.640 risen by 23.60%
$2,184 Application for quotation of securities - 4DX 15 Dec 2025 4:07PM $2.440 $3.640 risen by 49.18%
$2,184 Application for quotation of securities - 4DX 15 Dec 2025 4:03PM $2.440 $3.640 risen by 49.18%
$2,184 Update - Notification regarding unquoted securities - 4DX 15 Dec 2025 4:03PM $2.440 $3.640 risen by 49.18%
$2,184 Update - Notification regarding unquoted securities - 4DX 15 Dec 2025 4:02PM $2.440 $3.640 risen by 49.18%
$2,184 4DMedical secures regulatory approval for CTVQ in Canada 15 Dec 2025 9:40AM $2.220 $3.640 risen by 63.96%
$2,184 4DMedical secures $30.2 million with options underwrite 12 Dec 2025 9:34AM $2.040 $3.640 risen by 78.43%
$2,184 University of Miami adopts CTVQ 10 Dec 2025 9:34AM $2.000 $3.640 risen by 82%
$2,184 4DMedical secures US$10m CTVQ orders in Philips deal 3 Dec 2025 9:56AM $1.655 $3.640 risen by 119.94%
$2,184 Notification of upcoming expiry of Listed Options 1 Dec 2025 3:14PM $1.778 $3.640 risen by 104.78%
$2,184 Application for quotation of securities - 4DX 26 Nov 2025 3:44PM $1.595 $3.640 risen by 128.21%
$2,184 Application for quotation of securities - 4DX 17 Nov 2025 12:49PM $1.515 $3.640 risen by 140.26%
$2,184 Response to ASX Query Letter 5 Nov 2025 10:30AM $1.540 $3.640 risen by 136.36%
$2,184 Application for quotation of securities - 4DX 31 Oct 2025 11:48AM $1.780 $3.640 risen by 104.49%
$2,184 Results of AGM 30 Oct 2025 5:54PM $1.770 $3.640 risen by 105.65%
$2,184 Quarterly Activity Report and Appendix 4C 30 Oct 2025 10:12AM $1.825 $3.640 risen by 99.45%
$2,184 AGM Presentation and Chair's address 30 Oct 2025 9:00AM $1.830 $3.640 risen by 98.91%
$2,184 Annual General Meeting - Withdrawal of Resolution 29 Oct 2025 3:33PM $1.820 $3.640 risen by 100%
$2,184 Application for quotation of securities - 4DX 28 Oct 2025 4:47PM $1.790 $3.640 risen by 103.35%

101 - 125 of 594 results

Page 5 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.